Sign Up to like & get recommendations! 0
Published in 2018 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2018.05.037
Abstract: BACKGROUND AND AIMS Familial hypercholesterolaemia (FH) is an autosomal dominant lipoprotein disorder characterized by significant elevation of low-density lipoprotein cholesterol (LDL-C) and markedly increased risk of premature cardiovascular disease (CVD). Because of the very high… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2019.11.028
Abstract: BACKGROUND AND AIMS Familial hypercholesterolaemia (FH) is a common and preventable cause of premature heart attack but in most nations only a small proportion of FH-positive individuals have been identified. The aim of this study… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of clinical lipidology"
DOI: 10.1016/j.jacl.2020.12.012
Abstract: BACKGROUND Familial hypercholesterolemia (FH) is an autosomal dominant disorder mainly caused by mutations in the low-density lipoprotein (LDL) receptor or associated genes, resulting in elevated serum cholesterol levels and an increased risk of premature atherosclerotic… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Pediatric Nursing"
DOI: 10.1016/j.pedn.2018.09.011
Abstract: Problem Cardiovascular disease (CVD) is the leading cause of death in the U.S. and in most Western countries. Early identification and treatment of individuals with elevated levels of atherogenic cholesterol, a major contributor to CVD,… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)32548-1
Abstract: Familial hypercholesterolemia (FH) is an autosomal dominant disorder mainly caused by mutations in the low-density lipoprotein (LDL) receptor or associated genes, resulting in elevated serum cholesterol levels and an increased risk of premature atherosclerotic cardiovascular… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "European Journal of Human Genetics"
DOI: 10.1038/s41431-021-00974-y
Abstract: Low uptake of cascade screening for βeta-thalassaemia major (β-TM) in the ‘Punjab Thalassaemia Prevention Project’ (PTPP) in Pakistan led to the development of a ‘decision support intervention for relatives’ (DeSIRe). This paper presents the experiences… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.2983
Abstract: Early diagnosis and timely treatment for the patients with familial hypercholesterolemia (FH) can substantially lower the risk of atherosclerotic cardiovascular disease (ASCVD). In this sense, cascade screening could be one of the most useful options.… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Glaucoma"
DOI: 10.1097/ijg.0000000000001996
Abstract: Précis: Glaucoma cascade screening in first-degree relatives (FDRs) of young Haitian glaucoma patients had high yield for diagnosing manifest and suspected glaucoma in 30.8% of those screened despite modest participation. Purpose: To evaluate the outcomes… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "European journal of cancer care"
DOI: 10.1111/ecc.13577
Abstract: OBJECTIVE To overview the colonoscopy adherence in cascade screening of colorectal cancer (CRC) and evaluate potential influence of the initial tests based on an ecological evaluation. METHODS The performance of the initial screening tests and… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of gastroenterology and hepatology"
DOI: 10.1111/jgh.15762
Abstract: BACKGROUND AND AIM This study aims to systematically evaluate adherence-to-colonoscopy and related factors in cascade screening of colorectal cancer (CRC) among average-risk populations, which is crucial to achieve the effectiveness of CRC screening. METHODS We… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Pediatric Endocrinology and Metabolism"
DOI: 10.1515/jpem-2020-0234
Abstract: Abstract Objectives Premature coronary artery disease is the most common preventable cause of death in developed countries, and familial hypercholesterolemia (FH) is the most common monogenetic disorder of lipid metabolism, predisposing for premature coronary artery.… read more here.